Search Within

Paul Chapman

Formats
  1. Journal Article (205)
  2. Meeting Abstract (109)
  3. Book Section (8)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (326)
  2. Department of Medicine (326)
  3. Melanoma and Immunotherapeutics Service (326)
  4. Solid Tumor Oncology Division (326)
  5. GSK Faculty (133)
  6. Melanoma Disease Management Team (92)

More Groups

People
  1. Jedd Wolchok (107)
  2. Katherine Panageas (77)
  3. Alan Houghton (60)
  4. Michael Postow (54)
  5. Margaret Callahan (49)
  6. Alexander Shoushtari (45)

More People

Years
  1. 2024 (2)
  2. 2023 (8)
  3. 2022 (2)
  4. 2021 (9)
  5. 2020 (8)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Clinical Cancer Research (29)
  3. Cancer Research (15)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (13)
  5. New England Journal of Medicine (11)
  6. Cancer (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (60)
  3. Elsevier Inc. (22)
  4. Wiley Blackwell (19)
  5. Lippincott Williams & Wilkins (18)
  6. Oxford University Press (13)

More Publishers

Results (326)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Targeting tumor-rejection antigens in melanoma with tumor-infiltrating lymphocytes
    Editorial

    Chapman, P. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The state of melanoma: Emergent challenges and opportunities
    Review

    Atkins, M. B.; Curiel-Lewandrowski, C.; Fisher, D. E.; Swetter, S. M.; Tsao, H.; Aguirre-Ghiso, J. A.; Soengas, M. S.; Weeraratna, A. T.; Flaherty, K. T.; Herlyn, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The genetic evolution of treatment-resistant cutaneous, acral, and uveal melanomas
    Journal Article

    Makohon-Moore, A. P.; Lipson, E. J.; Hooper, J. E.; Zucker, A.; Hong, J.; Bielski, C. M.; Hayashi, A.; Tokheim, C.; Baez, P.; Kappagantula, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: Results from a North American expanded access program (CheckMate 218)
    Journal Article

    Hodi, F. S.; Chapman, P. B.; Sznol, M.; Lao, C. D.; Gonzalez, R.; Smylie, M.; Daniels, G. A.; Thompson, J. A.; Kudchadkar, R.; Sharfman, W.; more...
    Melanoma Research (2021)

    Fulltext@MSK | Save